{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:31:14Z","timestamp":1793741474282,"version":"4.6.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DBT\/JRF\/BET-16\/1\/2016\/AL\/37-458"],"award-info":[{"award-number":["DBT\/JRF\/BET-16\/1\/2016\/AL\/37-458"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.bioadv.2023.213661","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T12:02:11Z","timestamp":1697198531000},"page":"213661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["AS1411 aptamer tagged PEGylated liposomes as a smart nanocarrier for tumor-specific delivery of Withaferin A for mitigating pulmonary metastasis"],"prefix":"10.1016","volume":"154","author":[{"given":"Prathapan","family":"Abeesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillipe","family":"Bouvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrasekaran","family":"Guruvayoorappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2023.213661_bb0005","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","article-title":"Cancer metastasis: building a framework","volume":"127","author":"Gupta","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bioadv.2023.213661_bb0010","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevOncog.v20.i5-6.150","article-title":"Drug development for metastasis prevention","volume":"20","author":"Fontebasso","year":"2015","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.bioadv.2023.213661_bb0015","first-page":"1041","article-title":"Surgical and nonresectional therapies for pulmonary metastasis","volume":"90","author":"Zheng","year":"2010","journal-title":"Surg. Clin."},{"key":"10.1016\/j.bioadv.2023.213661_bb0020","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jama.2019.11058","article-title":"Systemic therapy for locally advanced and metastatic non\u2013small cell lung cancer: a review","volume":"322","author":"Arbour","year":"2019","journal-title":"Jama"},{"key":"10.1016\/j.bioadv.2023.213661_bb0025","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/S0140-6736(07)60781-8","article-title":"Metastasis: recent discoveries and novel treatment strategies","volume":"369","author":"Eccles","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bioadv.2023.213661_bb0030","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1158\/1940-6207.CAPR-20-0259","article-title":"A comprehensive review and perspective on anticancer mechanisms of withaferin A in breast cancer","volume":"13","author":"Hahm","year":"2020","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.bioadv.2023.213661_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107596","article-title":"Withaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells","volume":"9","author":"Kakar","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.bioadv.2023.213661_bb0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10456-004-1026-3","article-title":"Withaferin A is a potent inhibitor of angiogenesis","volume":"7","author":"Mohan","year":"2004","journal-title":"Angiogenesis"},{"key":"10.1016\/j.bioadv.2023.213661_bb0045","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/jnci\/djt153","article-title":"Metabolic alterations in mammary cancer prevention by withaferin A in a clinically relevant mouse model","volume":"105","author":"Hahm","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bioadv.2023.213661_bb0050","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.surg.2010.09.026","article-title":"A novel RET inhibitor with potent efficacy against medullary thyroid cancer in vivo","volume":"148","author":"Samadi","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.bioadv.2023.213661_bb0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaim.2018.12.008","article-title":"Safety and pharmacokinetics of Withaferin-A in advanced stage high grade osteosarcoma: A phase I trial","volume":"11","author":"Pires","year":"2020","journal-title":"J. Ayurveda Integr. Med."},{"key":"10.1016\/j.bioadv.2023.213661_bb0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/02841869609098486","article-title":"Antitumor and radiosensitizing effects of withaferin A on mouse Ehrlich ascites carcinoma in vivo","volume":"35","author":"Sharada","year":"1996","journal-title":"Acta Oncol."},{"key":"10.1016\/j.bioadv.2023.213661_bb0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/2231-4040.165023","article-title":"Evaluation of the bioavailability of major withanolides of Withania somnifera using an in vitro absorption model system","volume":"6","author":"Devkar","year":"2015","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.bioadv.2023.213661_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40169-017-0175-0","article-title":"Cancer nanomedicine: a review of recent success in drug delivery","volume":"6","author":"Tran","year":"2017","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bioadv.2023.213661_bb0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijpharm.2007.07.043","article-title":"Cremophor-free intravenous microemulsions for paclitaxel: II. stability, in vitro release and pharmacokinetics","volume":"349","author":"Nornoo","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2023.213661_bb0080","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1080\/21691401.2019.1646265","article-title":"Preparation, characterization and in vitro evaluation of PEGylated nanoliposomal containing etoposide on lung cancer","volume":"47","author":"Zare Kazemabadi","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.bioadv.2023.213661_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112335","article-title":"Preparation and characterization of withaferin A loaded pegylated nanoliposomal formulation with high loading efficacy: in vitro and in vivo anti-tumour study","volume":"128","author":"Abeesh","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.bioadv.2023.213661_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2021.102509","article-title":"Recent advances in active targeting of nanomaterials for anticancer drug delivery","volume":"296","author":"Dutta","year":"2021","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.bioadv.2023.213661_bb0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/1061186X.2015.1051049","article-title":"Nanocarriers for cancer-targeted drug delivery","volume":"24","author":"Kumari","year":"2016","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bioadv.2023.213661_bb0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1517\/17425240902780166","article-title":"Ligand-based targeted therapy for cancer tissue","volume":"6","author":"Das","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.bioadv.2023.213661_bb0105","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ijbiomac.2019.11.118","article-title":"Therapeutic applications of AS1411 aptamer, an update review","volume":"155","author":"Yazdian-Robati","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioadv.2023.213661_bb0110","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biochi.2015.03.023","article-title":"The roles of nucleolin subcellular localization in cancer","volume":"113","author":"Berger","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.bioadv.2023.213661_bb0115","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2019.01.045","article-title":"Aptamer-functionalized liposomes for targeted cancer therapy","volume":"448","author":"Moosavian","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioadv.2023.213661_bb0120","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tcb.2006.11.010","article-title":"Nucleolin: a multiFACeTed protein","volume":"17","author":"Mongelard","year":"2007","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bioadv.2023.213661_bb0125","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.15537\/smj.2016.12.15972","article-title":"Roles of nucleolin: focus on cancer and anti-cancer therapy","volume":"37","author":"Chen","year":"2016","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.bioadv.2023.213661_bb0130","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1007\/s13277-016-4920-6","article-title":"Prognostic significance of nuclear or cytoplasmic nucleolin expression in human non-small cell lung cancer and its relationship with DNA-PKcs","volume":"37","author":"Xu","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.bioadv.2023.213661_bb0135","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.febslet.2014.03.047","article-title":"Phosphorylation and changes in the distribution of nucleolin promote tumor metastasis via the PI3K\/Akt pathway in colorectal carcinoma","volume":"588","author":"Wu","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioadv.2023.213661_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-10-325","article-title":"Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice","volume":"10","author":"El Khoury","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bioadv.2023.213661_bb0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/path.2760","article-title":"Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells","volume":"222","author":"Zhuo","year":"2010","journal-title":"J. Pathol."},{"key":"10.1016\/j.bioadv.2023.213661_bb0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.colsurfb.2015.12.021","article-title":"Preparation and evaluation of polyethylenimine-functionalized carbon nanotubes tagged with 5TR1 aptamer for targeted delivery of Bcl-xL shRNA into breast cancer cells","volume":"140","author":"Taghavi","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bioadv.2023.213661_bb0155","doi-asserted-by":"crossref","first-page":"36219","DOI":"10.1039\/D0RA07325C","article-title":"Grafting of anti-nucleolin aptamer into preformed and remotely loaded liposomes through aptamer-cholesterol post-insertion","volume":"10","author":"Nsairat","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioadv.2023.213661_bb0160","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1016\/j.biomaterials.2014.01.019","article-title":"Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas","volume":"35","author":"Li","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2023.213661_bb0165","article-title":"Preparation and characterization of beta sitosterol encapsulated nanoliposomal formulation for improved delivery to cancer cells and evaluation of its anti-tumor activities against Daltons lymphoma ascites tumor models","volume":"70","author":"Abeesh","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2023.213661_bb0170","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.3390\/molecules27196295","article-title":"In situ swelling formulation of glycerol-monooleate-derived lyotropic liquid crystals proposed for local vaginal application","volume":"27","author":"Tarsitano","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioadv.2023.213661_bb0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1534735407302345","article-title":"Effect of amentoflavone on the inhibition of pulmonary metastasis induced by B16F-10 melanoma cells in C57BL\/6 mice","volume":"6","author":"Guruvayoorappan","year":"2007","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.bioadv.2023.213661_bb0180","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1039\/an9699400575","article-title":"Lung tissue hydrolysates: studies of the optimum conditions for the spectrophotometric determination of hydroxyproline","volume":"94","author":"Bergman","year":"1969","journal-title":"Analyst"},{"key":"10.1016\/j.bioadv.2023.213661_bb0185","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3891\/acta.chem.scand.02-0467","article-title":"The determination of hexosamines according to Elson and Morgan","volume":"2","author":"Blix","year":"1948","journal-title":"Acta Chem. Scand."},{"key":"10.1016\/j.bioadv.2023.213661_bb0190","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0003-2697(62)90095-7","article-title":"A modified uronic acid carbazole reaction","volume":"4","author":"Bitter","year":"1962","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioadv.2023.213661_bb0195","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1042\/bj1590457","article-title":"Stable thiobarbituric acid chromophore with dimethyl sulphoxide. Application to sialic acid assay in analytical de-O-acetylation","volume":"159","author":"Skoza","year":"1976","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.bioadv.2023.213661_bb0200","first-page":"131","article-title":"Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids","volume":"126","author":"Green","year":"1982"},{"key":"10.1016\/j.bioadv.2023.213661_bb0205","first-page":"1323","article-title":"Cell surface nucleolin as a promising receptor for effective AS1411 aptamer-mediated targeted drug delivery into cancer cells","volume":"15","author":"Mosafer","year":"2018"},{"key":"10.1016\/j.bioadv.2023.213661_bb0210","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.xphs.2016.02.021","article-title":"AS1411 aptamer-decorated biodegradable polyethylene glycol\u2013poly (lactic-co-glycolic acid) nanopolymersomes for the targeted delivery of gemcitabine to non\u2013small cell lung cancer in vitro","volume":"105","author":"Alibolandi","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2023.213661_bb0215","first-page":"657","article-title":"Targeting BAX to drug death directly, Nature chemical biology","volume":"15","author":"Walensky","year":"2019"},{"key":"10.1016\/j.bioadv.2023.213661_bb0220","first-page":"327","article-title":"Optimal multidisciplinary treatment of oral cavity mucosal melanoma: outcome analysis in a case series","volume":"28","author":"Perri","year":"2017"},{"key":"10.1016\/j.bioadv.2023.213661_bb0225","first-page":"327","article-title":"Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation","volume":"28","author":"Wei","year":"2008","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bioadv.2023.213661_bb0230","first-page":"1","article-title":"A novel function for vimentin: the potential biomarker for predicting melanoma hematogenous metastasis","volume":"29","author":"Li","year":"2010"},{"key":"10.1016\/j.bioadv.2023.213661_bb0235","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00864-2021","article-title":"Intracellular hydroxyproline imprinting following resolution of bleomycin-induced pulmonary fibrosis","volume":"59","author":"Song","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bioadv.2023.213661_bb0240","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/08923970600809017","article-title":"A preliminary study on antimetastatic activity of Thuja occidentalis L. in mice model","volume":"28","author":"Sunila","year":"2006","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.bioadv.2023.213661_bb0245","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1074\/jbc.R100037200","article-title":"Hyaluronan and homeostasis: a balancing act","volume":"277","author":"Tammi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioadv.2023.213661_bb0250","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1126\/science.2408340","article-title":"Angiogenesis induced by degradation products of hyaluronic acid","volume":"228","author":"West","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.bioadv.2023.213661_bb0255","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0304-3835(94)90047-7","article-title":"Evaluation of serum sialic acid fractions as markers for malignant melanoma","volume":"78","author":"Vedralov\u00e1","year":"1994","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioadv.2023.213661_bb0260","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0009-2797(97)00174-9","article-title":"Glutathione S-transferases\u2014biomarkers of cancer risk and chemopreventive response","volume":"111","author":"Clapper","year":"1998","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioadv.2023.213661_bb0265","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrc1910","article-title":"The role of nitric oxide in tumour progression","volume":"6","author":"Fukumura","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioadv.2023.213661_bb0270","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/019021490944232","article-title":"Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology","volume":"31","author":"Chakrabarti","year":"2005","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.bioadv.2023.213661_bb0275","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.4161\/cc.8.20.9699","article-title":"Inflammation: a driving force speeds cancer metastasis","volume":"8","author":"Wu","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bioadv.2023.213661_bb0280","first-page":"1369","article-title":"Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer","volume":"5","author":"Chen","year":"1999"},{"key":"10.1016\/j.bioadv.2023.213661_bb0285","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/embor.2009.243","article-title":"IKK\/NF-\u03baB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis","volume":"10","author":"Bollrath","year":"2009","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bioadv.2023.213661_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-10-437","article-title":"Correlation of NF-\u03baB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma","volume":"10","author":"Yan","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bioadv.2023.213661_bb0295","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI200421358","article-title":"NF-\u03baB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression","volume":"114","author":"Huber","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bioadv.2023.213661_bb0300","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1038\/sj.onc.1204535","article-title":"Blockade of NF-\u03baB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis","volume":"20","author":"Huang","year":"2001","journal-title":"Oncogene"}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950823003849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950823003849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T14:02:20Z","timestamp":1757426540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950823003849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":60,"alternative-id":["S2772950823003849"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2023.213661","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AS1411 aptamer tagged PEGylated liposomes as a smart nanocarrier for tumor-specific delivery of Withaferin A for mitigating pulmonary metastasis","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2023.213661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"213661"}}